ARS Pharmaceuticals, Inc.

SPRY · Nasdaq · SIC 2834: Pharmaceutical Preparations
93
SEC Filings

Business Summary

PART I . As used in this Annual Report, unless the context indicates or otherwise requires, ARS, ARS Pharma, the company, we, us, our, and other similar terms refer to ARS Pharmaceuticals, Inc., a Delaware corporation and its consolidated subsidiaries. neffy and EURneffy are trademarks of ours that we use in this Annual Report. This Annual Report also includes trademarks, trade names, and service marks that are the property of other organizations. Solely for convenience, our trademarks and trade...

Next Earnings

Q2 FY2026 — expected 2026-09-18

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSPRYdiscussed_in_filing Cybersecurity
topic_mentionSPRYdiscussed_in_filing Cybersecurity
topic_mentionSPRYdiscussed_in_filing Healthcare & Bio
topic_mentionSPRYdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001193125-26-097478EDGAR112K words
2025-03-202024-12-310000950170-25-042320EDGAR—
2024-03-212023-12-310000950170-24-034689EDGAR—
2023-03-232022-12-310000950170-23-009491EDGAR—
2022-03-312021-12-310000950170-22-005202EDGAR—
2021-03-292020-12-310001193125-21-098283EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001193125-25-273111EDGAR81K words
2025-08-132025-06-300000950170-25-107618EDGAR—
2025-05-142025-03-310000950170-25-070900EDGAR—
2024-11-132024-09-300000950170-24-125924EDGAR—
2024-08-062024-06-300000950170-24-091776EDGAR—
2024-05-092024-03-310000950170-24-056967EDGAR—
2023-11-092023-09-300000950170-23-061996EDGAR—
2023-08-102023-06-300000950170-23-041310EDGAR—
2023-05-152023-03-310000950170-23-021997EDGAR—
2022-11-022022-09-300000950170-22-021234EDGAR—
2022-08-112022-06-300000950170-22-016840EDGAR—
2022-05-122022-03-310000950170-22-009694EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-090001193125-26-097467EDGAR4K words
2025-11-100001193125-25-273107EDGAR—
2025-09-290001193125-25-223228EDGAR—
2025-08-280001193125-25-190202EDGAR—
2025-08-130000950170-25-107617EDGAR—
2025-06-260001193125-25-148922EDGAR—
2025-05-140000950170-25-070899EDGAR—
2025-05-020001193125-25-110696EDGAR—
2025-03-200000950170-25-042317EDGAR—
2025-03-050001193125-25-047351EDGAR—

93 total filings indexed. 65 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001671858
TickerSPRY
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6adab23999925b339101a947e840ebf837d8918a43f019f19d6a42f7a73558e4
parent: f0eb443adbce8278972f73496f1d041417c713383ced0ccd265021d68202763f
content hash: dd9972a70c992855db4062eec0590a1f204ba97001e2a878fd6675c84eb9f61b
signed: 2026-04-13T04:47:34.883Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf